Company: DVAX
Filing Date: 2025-04-15
Form Type: CORRESP
Source: 0000930413-25-001253
Chunk: 1

Company: DYNAVAX TECHNOLOGIES CORP
Filing Date: 2025-04-15
Form: CORRESP
Chunk 1
---
 company’s initial public offering and subsequent         
 rounds of financing                                                                                                                 
 •     CFO and VP Corporate                                                                                                          
 Development of ISTA Pharmaceuticals, Inc., a US-based pharmaceutical company that specialized in ophthalmic pharmaceutical          
 products until its sale to Bausch & Lomb (2003 - 2012)                                                                              
 Education                                                                                                                           
 •     M.B.A. in finance and                                                                                                         
 accounting from the Anderson Graduate School of Management at UCLA                                                                  
 •     B.A. in Biophysics from                                                                                                       
 the University of California, Berkeley                                                                                              |

| 2 | Committee appointment to be effective following Annual Meeting |

<div align='center'>* * *</div>

Please contact me at
(212) 479-6491 with any questions or further comments regarding our response to the Staff’s comments.

<div align='center'>Cooley LLP 55 Hudson Yards New York, NY 10001
t: (212) 479-6000 f: (212) 479-6275 cooley.com</div>

Sincerely,

/s/ Bill Roegge

Bill Roegge

| cc: | Steve Przesmicki, Cooley LLP |
|     | Barbara Borden, Cooley LLP   |

<div align='center'>Cooley LLP 55 Hudson Yards New York, NY 10001
t: (212) 479-6000 f: (212) 479-6275 cooley.com</div>